Avidity Biosciences Executives Sell Shares at $72.23 on 2026-01-07.

Avidity Biosciences, Inc. recently disclosed that its Director, President and CEO, Sarah Boyce, sold 8,576 shares at $72.23 per share on January 7, 2026. Additionally, Chief Technical Officer Charles III Calderaro sold 3,727 shares at the same price on the same date, as did Chief Scientific Officer Michael Flanagan W. and Chief Medical Officer Steven George Hughes, who both sold 2,373 shares at $72.23 per share. Furthermore, Chief Financial Officer Michael F. MacLean sold 1,974 shares and Chief Human Resources Officer Teresa McCarthy sold 1,965 shares at the aforementioned price. Lastly, Chief Legal Officer John B. Moriarty sold 2,374 shares at $72.23 per share on January 7, 2026.